NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,830,003 | -11.6% | 18,135 | -19.4% | 0.09% | -17.9% |
| Q1 2023 | $2,070,460 | -1.2% | 22,505 | -2.6% | 0.11% | -5.1% |
| Q4 2022 | $2,096,086 | +14.7% | 23,105 | -3.8% | 0.12% | +6.3% |
| Q3 2022 | $1,827,000 | -7.5% | 24,030 | +2.8% | 0.11% | +1.8% |
| Q2 2022 | $1,975,000 | -14.6% | 23,370 | -11.3% | 0.11% | -2.7% |
| Q1 2022 | $2,313,000 | -85.4% | 26,355 | -85.4% | 0.11% | -84.8% |
| Q4 2021 | $15,826,000 | +12.9% | 180,926 | +5.6% | 0.74% | -3.7% |
| Q3 2021 | $14,012,000 | -6.8% | 171,338 | +4.0% | 0.77% | -5.8% |
| Q2 2021 | $15,031,000 | +18.7% | 164,745 | +11.2% | 0.81% | +9.1% |
| Q1 2021 | $12,668,000 | +2.0% | 148,200 | +12.7% | 0.74% | -1.3% |
| Q4 2020 | $12,415,000 | +17.7% | 131,470 | +8.4% | 0.76% | -0.1% |
| Q3 2020 | $10,549,000 | +20.8% | 121,305 | +33.5% | 0.76% | -13.5% |
| Q1 2019 | $8,736,000 | +14.5% | 90,871 | +2.2% | 0.87% | -2.2% |
| Q4 2018 | $7,632,000 | -3.8% | 88,936 | -3.4% | 0.89% | +18.3% |
| Q3 2018 | $7,936,000 | +15.6% | 92,111 | +1.3% | 0.76% | +13.9% |
| Q2 2018 | $6,868,000 | -4.7% | 90,916 | +2.0% | 0.66% | -1.8% |
| Q1 2018 | $7,205,000 | +1.8% | 89,119 | +5.7% | 0.68% | +13.0% |
| Q4 2017 | $7,079,000 | -0.4% | 84,319 | +1.8% | 0.60% | -9.1% |
| Q3 2017 | $7,108,000 | +6.0% | 82,794 | +3.1% | 0.66% | -3.1% |
| Q2 2017 | $6,705,000 | +26.3% | 80,329 | +12.4% | 0.68% | +23.5% |
| Q1 2017 | $5,308,000 | +11.7% | 71,469 | +9.5% | 0.55% | +7.8% |
| Q4 2016 | $4,754,000 | -2.2% | 65,270 | +6.0% | 0.51% | -7.3% |
| Q3 2016 | $4,863,000 | -2.3% | 61,594 | +2.2% | 0.55% | +0.5% |
| Q2 2016 | $4,975,000 | +14.4% | 60,290 | +0.4% | 0.55% | +11.4% |
| Q1 2016 | $4,349,000 | -10.7% | 60,030 | +6.1% | 0.49% | -19.5% |
| Q4 2015 | $4,869,000 | -3.0% | 56,585 | +3.6% | 0.61% | -1.1% |
| Q3 2015 | $5,022,000 | -0.2% | 54,630 | +6.7% | 0.62% | +12.8% |
| Q2 2015 | $5,033,000 | +34.0% | 51,180 | +34.4% | 0.55% | +32.1% |
| Q1 2015 | $3,756,000 | +32.6% | 38,090 | +24.6% | 0.41% | +34.0% |
| Q4 2014 | $2,833,000 | +35.1% | 30,575 | +37.3% | 0.31% | +91.9% |
| Q3 2014 | $2,097,000 | -24.2% | 22,275 | -22.3% | 0.16% | -86.3% |
| Q2 2014 | $2,766,000 | +48.0% | 28,665 | +30.4% | 1.18% | +33.4% |
| Q1 2014 | $1,869,000 | – | 21,975 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |